Real-World Study of Intranasal Cell Therapy for Brain Injuries
Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Injuries & trauma, Mental health clinical trials.
This study follows people who receive intranasal stem cell or exosome therapy (tiny packages from special cells) for brain or neurological conditions like stroke, brain injury, or cerebral palsy. Researchers track how well the treatment works by measuring inflammation markers in the blood and monitoring clinical improvements over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosed neurological condition such as traumatic brain injury, stroke, cerebral palsy, or similar brain disorder
- You are receiving or have scheduled intranasal MuSE stem cell or exosome therapy as part of your medical care
- You can have a blood test to measure inflammation before treatment and during follow-up visits
- Your brain condition has been stable for at least 2 weeks before starting the study
- You do not have an active infection at the time of enrollment
- You are not taking strong immune-suppressing medications that could affect study measurements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This trial tests whether a single infusion of stem cells from donated umbilical cord tissue can help calm inflammation in the brain after severe traumatic brain injury. It is for patients aged 18–50 who need brain pressure monitoring and are not responding to verbal commands 5 days after sedation is stopped.
This early-stage study (Phase 1) tests whether a tiny dose given through the nose is safe for people who have had a stroke. It uses exosomes made from adult umbilical cord stem cells, mainly to look for side effects and dosing safety.
This early study tests whether an intravenous (through a vein) stem cell treatment made from donated umbilical cord tissue is safe for people with traumatic brain injury. It focuses mainly on side effects and safety, and only includes participants who meet several health and pregnancy-related safety checks.
This trial tests whether stem cells taken from your own fat and given through an IV can help people with long-term brain damage from a head injury. It is for adults who have not gotten better with standard treatments.
This study looks at the safety and outcomes of MUSE stem cell therapy for people with traumatic brain injury. If you have had a TBI at least 6 months ago and are planning to receive MUSE therapy outside the U.S., you may be able to join and help researchers learn more.
Hear when a new Traumatic Brain Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.